Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fresenius Medical Care AG (FMCQF) EPS (Weighted Average and Diluted) (2016 - 2023)

Historic EPS (Weighted Average and Diluted) for Fresenius Medical Care AG (FMCQF) over the last 13 years, with Q2 2023 value amounting to -$1567.7.

  • Fresenius Medical Care AG's EPS (Weighted Average and Diluted) changed N/A to -$1567.7 in Q2 2023 from the same period last year, while for Jun 2023 it was -$1567.7, marking a year-over-year change of. This contributed to the annual value of $1.96 for FY2024, which is 691.22% up from last year.
  • As of Q2 2023, Fresenius Medical Care AG's EPS (Weighted Average and Diluted) stood at -$1567.7.
  • In the past 5 years, Fresenius Medical Care AG's EPS (Weighted Average and Diluted) ranged from a high of -$359.86 in Q2 2020 and a low of -$1567.7 during Q2 2023
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$971.15 (2020), whereas its average is -$903.42.
  • The largest annual percentage gain for Fresenius Medical Care AG's EPS (Weighted Average and Diluted) in the last 5 years was 869.38% (2021), contrasted with its biggest fall of 5639.29% (2021).
  • Over the past 3 years, Fresenius Medical Care AG's EPS (Weighted Average and Diluted) (Quarter) stood at -$359.86 in 2020, then tumbled by 56.39% to -$562.8 in 2021, then crashed by 178.55% to -$1567.7 in 2023.
  • Its EPS (Weighted Average and Diluted) was -$1567.7 in Q2 2023, compared to -$562.8 in Q2 2021 and -$1055.6 in Q1 2021.